158 related articles for article (PubMed ID: 11016336)
1. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.
Jones DR; Broad RM; Madrid LV; Baldwin AS; Mayo MW
Ann Thorac Surg; 2000 Sep; 70(3):930-6; discussion 936-7. PubMed ID: 11016336
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation.
Jones DR; Broad RM; Comeau LD; Parsons SJ; Mayo MW
J Thorac Cardiovasc Surg; 2002 Feb; 123(2):310-7. PubMed ID: 11828291
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
Denlinger CE; Rundall BK; Keller MD; Jones DR
Ann Thorac Surg; 2004 Oct; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
[TBL] [Abstract][Full Text] [Related]
4. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
Rundall BK; Denlinger CE; Jones DR
Surgery; 2005 Aug; 138(2):360-7. PubMed ID: 16153448
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
Kim MK; Jeon YK; Woo JK; Choi Y; Choi DH; Kim YH; Kim CW
Mol Cancer; 2011 Aug; 10():98. PubMed ID: 21843371
[TBL] [Abstract][Full Text] [Related]
6. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
Rundall BK; Denlinger CE; Jones DR
Surgery; 2004 Aug; 136(2):416-25. PubMed ID: 15300209
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M
Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072
[TBL] [Abstract][Full Text] [Related]
8. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
Berman KS; Verma UN; Harburg G; Minna JD; Cobb MH; Gaynor RB
Clin Cancer Res; 2002 Feb; 8(2):354-60. PubMed ID: 11839649
[TBL] [Abstract][Full Text] [Related]
9. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species.
Karthik S; Sankar R; Varunkumar K; Anusha C; Ravikumar V
Biomed Pharmacother; 2015 Feb; 69():337-44. PubMed ID: 25661379
[TBL] [Abstract][Full Text] [Related]
10. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
Uwagawa T; Chiao PJ; Gocho T; Hirohara S; Misawa T; Yanaga K
Anticancer Res; 2009 Aug; 29(8):3173-8. PubMed ID: 19661331
[TBL] [Abstract][Full Text] [Related]
12. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer.
Camp ER; Li J; Minnich DJ; Brank A; Moldawer LL; MacKay SL; Hochwald SN
J Am Coll Surg; 2004 Aug; 199(2):249-58. PubMed ID: 15275881
[TBL] [Abstract][Full Text] [Related]
13. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.
Arlt A; Gehrz A; Müerköster S; Vorndamm J; Kruse ML; Fölsch UR; Schäfer H
Oncogene; 2003 May; 22(21):3243-51. PubMed ID: 12761494
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.
Gao ZW; Zhang DL; Guo CB
Curr Cancer Drug Targets; 2010 Nov; 10(7):705-15. PubMed ID: 20578985
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
[TBL] [Abstract][Full Text] [Related]
16. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM
Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
[TBL] [Abstract][Full Text] [Related]
17. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
Kunnumakkara AB; Sung B; Ravindran J; Diagaradjane P; Deorukhkar A; Dey S; Koca C; Yadav VR; Tong Z; Gelovani JG; Guha S; Krishnan S; Aggarwal BB
Cancer Res; 2010 Nov; 70(21):8695-705. PubMed ID: 20864511
[TBL] [Abstract][Full Text] [Related]
18. Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF- κB inactivation.
Xu TP; Shen H; Liu LX; Shu YQ
Asian Pac J Cancer Prev; 2013; 14(4):2325-31. PubMed ID: 23725135
[TBL] [Abstract][Full Text] [Related]
19. Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines.
Adachi S; Kokura S; Okayama T; Ishikawa T; Takagi T; Handa O; Naito Y; Yoshikawa T
Int J Hyperthermia; 2009 May; 25(3):210-9. PubMed ID: 19437237
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
Iwase R; Haruki K; Fujiwara Y; Furukawa K; Shiba H; Uwagawa T; Misawa T; Ohashi T; Yanaga K
J Surg Res; 2013 Sep; 184(1):605-12. PubMed ID: 23830367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
